Early response or nonresponse at week 2 and week 3 predict ultimate response or nonresponse in adolescents with schizophrenia treated with olanzapine: results from a 6-week randomized, placebo-controlled trial

[1]  D. Rujescu,et al.  Early Improvement As a Predictor of Later Response to Antipsychotics in Schizophrenia: A Diagnostic Test Review. , 2015, The American journal of psychiatry.

[2]  C. Correll,et al.  Clinical predictors of therapeutic response to antipsychotics in schizophrenia , 2014, Dialogues in clinical neuroscience.

[3]  J. Azorin,et al.  Trajectories of antipsychotic response in drug‐naive schizophrenia patients: results from the 6‐month ESPASS follow‐up study , 2014, Acta psychiatrica Scandinavica.

[4]  T. Kishimoto,et al.  Early nonresponse determined by the clinical global impressions scale predicts poorer outcomes in youth with schizophrenia spectrum disorders naturalistically treated with second-generation antipsychotics. , 2013, Journal of child and adolescent psychopharmacology.

[5]  C. Correll,et al.  Early antipsychotic response to aripiprazole in adolescents with schizophrenia: predictive value for clinical outcomes. , 2013, Journal of the American Academy of Child and Adolescent Psychiatry.

[6]  R. Tabarés-Seisdedos,et al.  Trajectories of symptom dimensions in short-term response to antipsychotic treatment in patients with a first episode of non-affective psychosis , 2013, Psychological Medicine.

[7]  H. Steinhausen,et al.  A systematic review of the long-term outcome of early onset schizophrenia , 2012, BMC Psychiatry.

[8]  H. Möller,et al.  Response trajectories in “real-world” naturalistically treated schizophrenia patients , 2012, Schizophrenia Research.

[9]  H. Möller,et al.  Influencing factors and predictors of early improvement in the acute treatment of schizophrenia and schizophrenia spectrum disorder. , 2011, Journal of Psychiatric Research.

[10]  D. Robinson,et al.  Time to treatment response in first-episode schizophrenia: should acute treatment trials last several months? , 2011, The Journal of clinical psychiatry.

[11]  J. Lieberman,et al.  Early response to antipsychotic therapy as a clinical marker of subsequent response in the treatment of patients with first-episode psychosis , 2011, Psychiatry Research.

[12]  H. Möller,et al.  Predictors of response and remission in the acute treatment of first-episode schizophrenia patients — Is it all about early response? , 2011, European Neuropsychopharmacology.

[13]  Y. Sudo,et al.  Difference in early prediction of antipsychotic non-response between risperidone and olanzapine in the treatment of acute-phase schizophrenia , 2011, Schizophrenia Research.

[14]  R. Conley,et al.  Identification of early changes in specific symptoms that predict longer-term response to atypical antipsychotics in the treatment of patients with schizophrenia , 2011, BMC psychiatry.

[15]  S. Leucht,et al.  Elaboration on the Early-Onset Hypothesis of Antipsychotic Drug Action: Treatment Response Trajectories , 2010, Biological Psychiatry.

[16]  H. Möller,et al.  An early improvement threshold to predict response and remission in first-episode schizophrenia , 2010, British Journal of Psychiatry.

[17]  R. Kahn,et al.  Antipsychotic Drug Treatment in First-Episode Psychosis: Should Patients be Switched to a Different Antipsychotic Drug After 2, 4, or 6 Weeks of Nonresponse? , 2010, Journal of clinical psychopharmacology.

[18]  S. Kapur,et al.  Early Response to Antipsychotic Drug Therapy as a Clinical Marker of Subsequent Response in the Treatment of Schizophrenia , 2010, Neuropsychopharmacology.

[19]  C. McDougle,et al.  Olanzapine versus placebo in adolescents with schizophrenia: a 6-week, randomized, double-blind, placebo-controlled trial. , 2009, Journal of the American Academy of Child and Adolescent Psychiatry.

[20]  R. Findling,et al.  A multiple-center, randomized, double-blind, placebo-controlled study of oral aripiprazole for treatment of adolescents with schizophrenia. , 2008, The American journal of psychiatry.

[21]  Ann E. Maloney,et al.  Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizo-affective disorder: findings from the treatment of early-onset schizophrenia spectrum disorders (TEOSS) study. , 2008, The American journal of psychiatry.

[22]  M. Tohen,et al.  Tardive dyskinesia and the 3-year course of schizophrenia: results from a large, prospective, naturalistic study. , 2008, The Journal of clinical psychiatry.

[23]  J. Kane,et al.  Predicting response to atypical antipsychotics based on early response in the treatment of schizophrenia , 2008, Schizophrenia Research.

[24]  J. Kane,et al.  Predicting antipsychotic drug response – Replication and extension to six weeks in an international olanzapine study , 2008, Schizophrenia Research.

[25]  R. Baker,et al.  Clinical, Functional, and Economic Ramifications of Early Nonresponse to Antipsychotics in the Naturalistic Treatment of Schizophrenia , 2007, Schizophrenia bulletin.

[26]  J. Vázquez-Barquero,et al.  Predictors of acute treatment response in patients with a first episode of non-affective psychosis: sociodemographics, premorbid and clinical variables. , 2007, Journal of psychiatric research.

[27]  J. Lieberman,et al.  Neuroprotection: A New Strategy in the Treatment of Schizophrenia , 2007, CNS Spectrums.

[28]  J. Kane,et al.  Early prediction of antipsychotic nonresponse among patients with schizophrenia. , 2007, The Journal of clinical psychiatry.

[29]  Alexander L. Miller,et al.  First-Episode Psychosis: A Window of Opportunity for Best Practices , 2007, CNS Spectrums.

[30]  Yue-Cune Chang,et al.  Optimizing Early Prediction for Antipsychotic Response in Schizophrenia , 2006, Journal of clinical psychopharmacology.

[31]  R. Emsley,et al.  Remission in first-episode psychosis: predictor variables and symptom improvement patterns. , 2006, The Journal of clinical psychiatry.

[32]  R. Emsley,et al.  Time course for antipsychotic treatment response in first-episode schizophrenia. , 2006, The American journal of psychiatry.

[33]  S. Kapur,et al.  The "delayed onset" of antipsychotic action--an idea whose time has come and gone. , 2006, Journal of psychiatry & neuroscience : JPN.

[34]  B. Kinon,et al.  Discontinuation of treatment of schizophrenic patients is driven by poor symptom response: a pooled post-hoc analysis of four atypical antipsychotic drugs , 2005, BMC medicine.

[35]  Stefan Leucht,et al.  Clinical implications of Brief Psychiatric Rating Scale scores. , 2005, The British journal of psychiatry : the journal of mental science.

[36]  J. Kane,et al.  Early-Onset Hypothesis of Antipsychotic Drug Action: A Hypothesis Tested, Confirmed and Extended , 2005, Biological Psychiatry.

[37]  D. Weinberger,et al.  Remission in schizophrenia: proposed criteria and rationale for consensus. , 2005, The American journal of psychiatry.

[38]  R. Findling,et al.  Pharmacologic treatment of adolescent and child schizophrenia , 2004, Expert review of neurotherapeutics.

[39]  A. Malhotra,et al.  Early prediction of antipsychotic response in schizophrenia. , 2003, The American journal of psychiatry.

[40]  S. Kapur,et al.  Delayed onset hypothesis of antipsychotic action — a hypothesis tested and rejected , 2003, Schizophrenia Research.

[41]  E. Laska,et al.  Recovery from psychotic illness: A 15- and 25-year international follow-up study , 2001, British Journal of Psychiatry.

[42]  N. Ryan,et al.  Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.

[43]  T. Barnes.  A Rating Scale for Drug-Induced Akathisia , 1989, British Journal of Psychiatry.

[44]  S. Kay,et al.  The positive and negative syndrome scale (PANSS) for schizophrenia. , 1987, Schizophrenia bulletin.

[45]  J. Endicott,et al.  The Overt Aggression Scale for the objective rating of verbal and physical aggression. , 1986, The American journal of psychiatry.

[46]  B. Pfefferbaum,et al.  The Brief Psychiatric Rating Scale for Children. , 1982, Psychopharmacology bulletin.

[47]  J. Kane,et al.  Research diagnoses for tardive dyskinesia. , 1982, Archives of general psychiatry.

[48]  G. Simpson,et al.  A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS , 1970, Acta psychiatrica Scandinavica. Supplementum.